- Published on
Ophthalmology – Choroidal Neovascularization
Choroidal neovascularization (CNV) refers to the formation of abnormal new blood vessels originating from the choroid that penetrate through defects in Bruch’s membrane into the subretinal space. These vessels often form a fibrovascular complex that is fragile and prone to leakage, leading to accumulation of fluid, lipid exudation, and hemorrhage. Over time, this process can result in the formation of a disciform scar and permanent vision loss. CNV is not a standalone disease but a complication of many underlying disorders affecting the retinal pigment epithelium (RPE)–Bruch’s membrane–choriocapillaris complex.
Epidemiologically, the incidence and prevalence of CNV vary depending on the underlying condition. It is most commonly associated with age-related macular degeneration (AMD), which is the leading cause of irreversible vision loss in individuals over 65 years in developed countries. Advanced AMD affects tens of millions of people worldwide. The likelihood of developing CNV increases significantly with age and is influenced by systemic and genetic factors.
Risk factors depend largely on the underlying disease. In AMD-related CNV, advancing age, smoking, hypertension, hyperlipidemia, obesity, and reduced physical activity play significant roles. A strong family history also increases risk, reflecting a genetic predisposition. Genetic studies, including twin studies and genome-wide analyses, support the multifactorial inheritance pattern of AMD and its complications such as CNV.
The pathophysiology involves disruption of Bruch’s membrane, which allows neovascular tissue from the choriocapillaris to grow into the subretinal space. This process is driven by proangiogenic factors such as vascular endothelial growth factor (VEGF), platelet-derived growth factor, and other inflammatory mediators. CNV can be classified based on its location relative to the RPE, including type 1 (sub-RPE), type 2 (subretinal), or mixed forms.
Clinically, patients typically present with sudden onset of decreased central vision, often accompanied by metamorphopsia and paracentral scotomas. On examination, findings may include RPE elevation, subretinal fluid, lipid exudates, hemorrhage, and a gray-green lesion beneath the retina. These features reflect the leakage and instability of the neovascular membrane.
Diagnosis is primarily made using imaging techniques. Fluorescein angiography helps identify leakage patterns and differentiate between classic and occult CNV. Optical coherence tomography (OCT) is essential for detecting structural changes such as subretinal fluid, intraretinal edema, and RPE detachment, and is also useful for monitoring response to treatment.
Management has evolved significantly with the advent of anti-VEGF therapy, which is now the standard of care. Intravitreal injections of agents such as ranibizumab or bevacizumab inhibit neovascular growth and reduce leakage, often stabilizing or improving vision. In selected cases, particularly extrafoveal lesions or non-AMD etiologies, laser photocoagulation or photodynamic therapy may be considered. Surgical options such as vitrectomy are reserved for complications like submacular hemorrhage.
The prognosis depends on the location of the lesion and the extent of damage at presentation. Early detection and treatment significantly improve visual outcomes. However, recurrence is common, requiring ongoing monitoring with tools such as the Amsler grid and serial imaging.
Complications include subretinal fibrosis, persistent or recurrent fluid accumulation, and, in severe cases, massive subretinal hemorrhage that can lead to retinal detachment and profound vision loss.
- Published on
Ophthalmology – Choroidal Melanoma
Choroidal melanoma is the most common primary intraocular malignancy, arising from melanocytes within the uveal tract. The majority of cases (about 90%) involve the choroid, with smaller proportions affecting the iris or ciliary body. These tumors may appear pigmented, nonpigmented, or mixed, and typically present as dome-shaped, mushroom-shaped, or diffuse lesions. They are often associated with subretinal fluid, orange pigment (lipofuscin), and occasionally hemorrhage. Any suspicious pigmented lesion in the fundus must be carefully evaluated for possible melanoma.
Epidemiologically, choroidal melanoma most commonly occurs in middle-aged adults, with a median age of around 55 years. It is more prevalent in fair-skinned, blue-eyed individuals, particularly those with a tendency to sunburn. The incidence in the United States is approximately 4–6 cases per million in Caucasians and lower in other populations. Although rare in children, it can occur in all age groups. Approximately 2,500 new cases are diagnosed annually in the United States.
Risk factors include light skin pigmentation, oculodermal melanocytosis (Nevus of Ota), and preexisting choroidal nevi with high-risk features such as increased thickness, subretinal fluid, symptoms, and the presence of orange pigment. Genetic studies have shown that chromosomal abnormalities, particularly monosomy 3 and duplication of chromosome 8q, are associated with a worse prognosis and increased risk of metastasis.
The pathophysiology involves malignant transformation of melanocytes within the choroid. These tumors may arise de novo or from preexisting benign lesions such as choroidal nevi. As the tumor grows, it can disrupt surrounding structures, leading to retinal detachment, photoreceptor damage, and vision loss.
Clinically, patients may present with decreased vision, flashes, floaters, or may remain asymptomatic in early stages. On examination, the tumor typically appears as a pigmented or amelanotic mass, most commonly located in the posterior segment. Associated findings may include subretinal fluid, retinal detachment, and lipofuscin deposits. The lesion’s size, location, and proximity to the optic disc or fovea are important in determining prognosis and management.
Diagnosis relies on clinical examination and multimodal imaging. Fundus photography, ultrasonography, fluorescein angiography, indocyanine green angiography, and optical coherence tomography are commonly used. Ultrasonography is particularly useful in identifying the internal acoustic characteristics of the tumor. In selected cases, fine needle aspiration biopsy may be performed to confirm diagnosis and evaluate cytogenetic markers. Systemic evaluation, including liver function tests and imaging such as liver MRI or PET scan, is essential to detect metastasis, as the liver is the most common site of spread.
Management depends on tumor size, location, and patient factors. Treatment options include plaque radiotherapy, proton beam therapy, surgical resection, transpupillary thermotherapy, and enucleation. Plaque radiotherapy and proton beam therapy are commonly used for small to medium-sized tumors and offer high rates of local tumor control. Enucleation is reserved for large tumors or those with complications such as glaucoma or extraocular extension.
Prognosis is closely related to tumor size and genetic features. The risk of metastasis increases with tumor thickness, ranging from approximately 12% for small tumors to 50% for large tumors at 10 years. Despite effective local control, metastatic disease significantly worsens survival. Visual outcomes depend on tumor location and treatment modality, with many patients experiencing vision loss after radiotherapy.
Complications vary depending on treatment. Enucleation may result in cosmetic and socket-related issues, while radiotherapy can lead to radiation retinopathy, optic neuropathy, cataract, glaucoma, and eventual loss of the eye. Lifelong follow-up is essential to monitor for recurrence and systemic metastasis.
- Published on
Ophthalmology – Choroidal Hemangioma
Choroidal hemangioma is a benign vascular tumor of the choroid composed of abnormal blood vessels. It exists in two main forms: circumscribed choroidal hemangioma (CCH), which is a localized solitary lesion without systemic associations, and diffuse choroidal hemangioma (DCH), which is typically associated with Sturge–Weber syndrome. While both forms are benign, they can significantly affect vision due to associated retinal changes.
Epidemiologically, CCH is rare, and DCH is even rarer. CCH typically presents in adulthood, often between the third and sixth decades of life, whereas DCH tends to present earlier, often in childhood or adolescence. There are no known genetic risk factors for CCH, while DCH occurs as part of Sturge–Weber syndrome, a sporadic neurocutaneous disorder characterized by vascular malformations involving the skin, brain, and eye.
The pathophysiology involves proliferation of thin-walled vascular channels within the choroid. These vascular spaces can leak fluid, leading to accumulation of subretinal fluid and serous retinal detachment. Chronic leakage may result in retinal pigment epithelium (RPE) changes, photoreceptor damage, and eventual visual impairment.
Clinically, patients often present with painless visual loss or metamorphopsia. On examination, circumscribed choroidal hemangioma appears as a unilateral, round or oval, orange-red elevated lesion located posterior to the equator. It is frequently associated with serous retinal detachment and overlying retinal changes such as edema or RPE alterations. Diffuse choroidal hemangioma, in contrast, presents as widespread thickening of the choroid, giving a characteristic “tomato ketchup” appearance of the fundus. In these cases, other ocular and systemic features of Sturge–Weber syndrome—such as episcleral vessel dilation and glaucoma—are often present.
Diagnostic evaluation includes multimodal imaging. Fluorescein angiography typically shows early hyperfluorescence with progressive leakage. Indocyanine green angiography demonstrates early intense hyperfluorescence followed by a characteristic “washout” pattern in later phases. Ultrasonography reveals a dome-shaped lesion with high internal reflectivity, similar to normal choroidal tissue. Optical coherence tomography is useful in detecting associated retinal changes such as subretinal fluid or macular edema and is particularly helpful for monitoring treatment response.
Management depends on symptoms and the risk to vision. Asymptomatic lesions without vision-threatening complications can be observed. Treatment is indicated when there is subretinal fluid or involvement of the macula. Photodynamic therapy (PDT) with verteporfin is the treatment of choice for circumscribed lesions and is also effective in diffuse cases. Other options include external beam radiotherapy and plaque radiotherapy, particularly in cases not amenable to PDT. Laser photocoagulation and transpupillary thermotherapy are less commonly used due to higher risks of tissue damage.
Prognosis depends largely on the duration and extent of retinal involvement. Early treatment of vision-threatening lesions improves outcomes, while delayed treatment may result in permanent photoreceptor and RPE damage. Complications include persistent serous retinal detachment and, in advanced cases, neovascular glaucoma, which can lead to severe vision loss and may require enucleation. Regular follow-up is essential to monitor for recurrence or progression.
- Published on
Ophthalmology – Choroidal Folds
Choroidal folds are parallel striae seen at the posterior pole of the eye and may be oriented horizontally, vertically, or obliquely. They are not a disease themselves but rather a clinical sign that can be idiopathic or associated with a variety of ocular, orbital, or systemic conditions. Their presence should always prompt evaluation for an underlying cause.
The exact epidemiology of choroidal folds is unknown. They may occur in a wide range of patients depending on the associated underlying condition. Since they are often asymptomatic, many cases may go undetected unless identified during routine fundus examination.
The pathophysiology involves wrinkling of the retinal pigment epithelium (RPE), Bruch’s membrane, and inner choroidal layers. This is believed to result from an imbalance between forces acting on the globe. These forces may be internal, such as hypotony, or external, such as orbital masses or increased intracranial pressure. Direct tractional forces, for example from choroidal neovascular membranes, can also contribute. The characteristic appearance of alternating light and dark bands reflects structural changes in the RPE and choroid.
Etiologically, many cases are idiopathic, but secondary causes are common and must be considered. Ocular causes include choroidal tumors, neovascularization, inflammation, hypotony, posterior scleritis, uveal effusion, central serous chorioretinopathy, and prior scleral buckle surgery. Optic nerve-related causes include papilledema and optic nerve tumors. Orbital conditions such as tumors, inflammation, or thyroid eye disease may also lead to folds. Additionally, increased intracranial pressure alone can produce choroidal folds, even in the absence of papilledema.
Clinically, patients may be asymptomatic or may report blurred vision or metamorphopsia. On funduscopic examination, choroidal folds appear as alternating light (yellow) and dark (orange) parallel lines at the posterior pole. A comprehensive ocular examination, including intraocular pressure measurement, is essential to help identify any underlying pathology.
Diagnostic imaging plays an important role. Fluorescein angiography typically demonstrates an alternating pattern of hyperfluorescence and hypofluorescence corresponding to stretched and compressed areas of the RPE. Optical coherence tomography (OCT) can clearly show undulations of the RPE and helps differentiate choroidal folds from retinal folds. Fundus autofluorescence may also provide supportive findings. If an underlying cause is suspected, further orbital imaging such as B-scan ultrasonography, CT, or MRI may be required.
Management of choroidal folds is directed toward treating the underlying cause. In cases where no cause is identified and the patient is asymptomatic, observation with periodic follow-up is appropriate. Serial fundus examinations are recommended to monitor for changes or the emergence of an underlying condition.
- Published on
Ophthalmology – Choroidal Effusion / Detachment
Choroidal effusion or detachment refers to the accumulation of fluid, either serous or hemorrhagic, in the suprachoroidal space. It occurs when fluid or blood collects between the choroid and sclera due to altered pressure relationships or increased vascular permeability. These detachments may occur after trauma, during or after ocular surgery, or more rarely, spontaneously. Serous detachments are often less dramatic in presentation, whereas hemorrhagic choroidal detachments can be painful and visually devastating.
The incidence varies widely, reported between 0.05% and 6%, depending on the clinical setting. There is no clear racial or sex predilection, although hemorrhagic choroidal detachments are more common in elderly patients. Risk factors for serous choroidal effusion include nanophthalmos, uveal effusion syndrome, carotid-cavernous fistula, intraocular inflammation, hypotony, trauma, scleritis, Vogt-Koyanagi-Harada syndrome, tumors, and certain medications. Hemorrhagic detachments are associated with older age, arteriosclerosis, systemic hypertension, uncontrolled glaucoma, myopia, prior ocular surgery, sickle cell disease, and a history of choroidal hemorrhage in the fellow eye. Surgical risk factors include wound leaks, scleral perforation, cyclodialysis clefts, leaking blebs, and prior laser or cryotherapy.
The pathophysiology depends on changes in the balance among intraocular pressure, vascular hydrostatic pressure, and oncotic pressure within the suprachoroidal space. Increased vascular permeability allows serum proteins and fluid to exude into this potential space, causing choroidal edema and detachment. In many cases, hypotony is a major precipitating factor. Hemorrhagic detachments occur when blood enters the same space, often after a sudden pressure change or vessel rupture.
Clinically, serous choroidal effusions often cause painless decreased vision and are frequently associated with low intraocular pressure, a shallow anterior chamber, and mild anterior chamber inflammation. On fundus examination, they appear as smooth, bullous, orange elevations of the choroid and retina, often extending circumferentially in the periphery with a lobulated contour. In contrast, hemorrhagic choroidal detachments usually present suddenly with severe pain, marked vision loss, a red eye, and are often associated with elevated intraocular pressure. A careful history should assess for recent surgery, trauma, laser treatment, straining, coughing, Valsalva, and the use of anticoagulants or aspirin.
On examination, it is important to look for evidence of a wound leak, filtering bleb, cyclodialysis cleft, or signs of recent ocular intervention. Seidel testing and gonioscopy may be helpful in identifying the source of hypotony. In selected cases, scalp and skin examination may help identify associated systemic inflammatory disease, such as vitiligo or alopecia in Vogt-Koyanagi-Harada syndrome.
B-scan ultrasonography is the most useful diagnostic tool and typically shows dome-shaped choroidal elevations with low-to-medium internal reflectivity. It helps distinguish serous from hemorrhagic detachments, assesses whether blood is mobile or clotted, and identifies severe appositional detachments known as “kissing choroidals.” Additional imaging such as CT or MRI may help differentiate choroidal effusion from tumors like choroidal melanoma. Transillumination may be positive in serous detachments, whereas hemorrhagic detachments typically do not transilluminate.
Management depends on the underlying cause. Initial treatment includes topical corticosteroids and cycloplegics, along with intraocular pressure control using topical or systemic medications. Oral steroids may be considered when inflammation is a contributing factor. Parasympathomimetic agents are contraindicated as they may worsen the condition.
Surgical intervention may be required if the detachment persists or is severe. Options include posterior sclerotomy to drain suprachoroidal fluid, anterior chamber paracentesis, or injection of viscoelastic substances if the anterior chamber is shallow or flat.
Prognosis depends largely on the underlying etiology. While there is no associated mortality, up to 40% of patients may experience significant vision loss. Hemorrhagic choroidal detachments generally carry a worse prognosis. Potential complications include retinal detachment, cataract formation, glaucoma, corneal endothelial damage, peripheral anterior synechiae, and in severe cases, phthisis bulbi.
- Published on
Ophthalmology – Child Abuse
Child abuse and neglect, as defined by the Child Abuse Prevention and Treatment Act (CAPTA), refers to any act or failure to act by a caregiver that results in death or serious physical or emotional harm to a child. This includes physical abuse, neglect, and sexual exploitation. In ophthalmology, particular importance is given to abusive head trauma, including shaken baby syndrome (SBS), which is characterized by retinal hemorrhages, intracranial bleeding, and brain injury, often with minimal external signs of trauma. Neglect involves failure to provide essential needs such as food, shelter, supervision, medical care, and education.
Epidemiologically, child abuse remains a major public health concern. Millions of cases are reported annually, with hundreds of thousands confirmed and thousands of deaths each year. Infants and very young children are at the highest risk, particularly those under one year of age. While abuse affects all demographics, certain populations show higher risk rates. Most perpetrators are caregivers, often parents, and contributing factors include social stressors, substance abuse, and underlying family instability.
The pathophysiology of abusive head trauma involves rotational acceleration–deceleration forces that lead to tearing of bridging veins, causing subdural and subarachnoid hemorrhages, as well as diffuse axonal brain injury. Ocular findings result from vitreoretinal traction, producing extensive retinal hemorrhages that are often multilayered and extend to the peripheral retina. In severe cases, traction may also cause retinoschisis and retinal folds. These ocular findings are highly suggestive of abuse, especially when they are numerous and extend beyond the posterior pole.
The diagnosis of child abuse requires a high index of suspicion. Retinal hemorrhages are present in the majority of shaken baby syndrome cases and are often too numerous to count. Clinically, concern should arise when there is a delay in seeking care, inconsistent or changing history, or injuries that are not developmentally plausible. A detailed and carefully documented history is essential, including a clear timeline of events.
On physical examination, a complete systemic evaluation is necessary. Ocular examination with dilated funduscopy is critical and should be performed promptly by an ophthalmologist. Findings may include preretinal, intraretinal, or subretinal hemorrhages, often extending to the ora serrata. Retinoschisis with associated retinal folds is particularly indicative of abusive trauma. Other ocular signs such as hyphema, lens dislocation, or periocular bruising should raise suspicion in the absence of a clear accidental cause. Documentation, including detailed descriptions and photographs when available, is essential for both medical and legal purposes.
Diagnostic evaluation includes imaging and laboratory studies guided by clinical findings. Neuroimaging with CT or MRI often reveals subdural hematomas, cerebral edema, or diffuse axonal injury. A full skeletal survey is recommended in young children to identify occult fractures, especially rib and long bone injuries. Laboratory testing may be used to rule out alternative diagnoses such as coagulopathies or metabolic disorders. While retinal photography can assist in documentation, it does not replace a thorough clinical examination.
Management of suspected child abuse is multidisciplinary and urgent. Immediate priorities include stabilization of any life-threatening conditions. Hospitalization is often required for both medical evaluation and protection of the child. Physicians are legally mandated to report suspected abuse to child protective services, even if the diagnosis is not definitively proven. Long-term care involves coordination between medical providers, social services, and mental health professionals to address the needs of the child and family.
Prognosis depends on the severity of injury. Mortality rates in abusive head trauma range from 15% to 38%, and survivors often suffer long-term neurologic and visual complications. These may include cortical visual impairment, optic atrophy, amblyopia, and developmental delays. Severe brain injury correlates strongly with poor visual outcomes. Complications can be profound, including permanent disability, seizures, cerebral palsy, and in the worst cases, death.
- Published on
Ophthalmology – Chiasmal Disorders
Chiasmal disorders involve pathology affecting the optic chiasm, the structure where nasal retinal fibers from each optic nerve cross. Anatomically, the chiasm lies just above the sella turcica and plays a crucial role in binocular vision by transmitting visual information from both eyes to the brain. Because of this arrangement, lesions in this region classically produce characteristic visual field defects. Visual impairment is often the earliest and most prominent symptom, and notably, nearly one-quarter of all brain tumors occur in the region of the optic chiasm.
The epidemiology of chiasmal disorders is variable and depends on the underlying cause. Pituitary adenomas are among the most common etiologies, with an estimated incidence of about 5 per 100,000 individuals. Visual loss occurs in a significant proportion of these patients, ranging from 30% to 90%. Risk factors include prior radiation exposure and genetic conditions such as neurofibromatosis and multiple endocrine neoplasia. Some inflammatory and demyelinating conditions like multiple sclerosis and sarcoidosis also have genetic predispositions that may involve the chiasm.
Pathophysiologically, most chiasmal syndromes result from compression of the optic chiasm by lesions in the sellar or parasellar region. The crossing nasal fibers are particularly vulnerable, leading to loss of temporal visual fields. Other mechanisms include infiltration, inflammation, ischemia, or trauma. Causes can be intrinsic (such as gliomas) or extrinsic, with extrinsic compressive lesions being the most common. These include pituitary adenomas, craniopharyngiomas, and meningiomas.
Patients often present with visual disturbances such as blurred vision, decreased visual acuity, or visual field defects. The hallmark finding is bitemporal hemianopia, although other patterns like quadrantanopia or junctional scotomas may occur depending on the lesion’s location. Additional symptoms may include diplopia from involvement of adjacent cranial nerves, headache, facial pain, and hormonal disturbances such as amenorrhea, galactorrhea, infertility, or decreased libido due to pituitary involvement. Rare symptoms include oscillopsia and see-saw nystagmus.
On examination, early visual acuity and color vision may remain normal, but visual field testing reveals characteristic defects. A relative afferent pupillary defect may be present if involvement is asymmetric. Over time, optic disc pallor develops in a distinctive “bow-tie” pattern due to selective involvement of nasal and papillomacular fibers. Cranial nerve examination may reveal deficits in nerves III, IV, V, and VI, particularly if the cavernous sinus is involved.
Diagnosis relies heavily on imaging and laboratory evaluation. MRI of the brain and sella with contrast is the investigation of choice, as it provides detailed visualization of soft tissue structures including the optic chiasm. Hormonal evaluation, especially prolactin levels, is important when pituitary lesions are suspected. Optical coherence tomography (OCT) may demonstrate thinning of the retinal nerve fiber layer, supporting the diagnosis. In acute scenarios such as pituitary apoplexy, rapid imaging and intervention are critical.
Management depends on the underlying cause. Corticosteroids are used in inflammatory conditions and acute situations like pituitary apoplexy. Dopamine agonists such as bromocriptine and cabergoline are effective in shrinking prolactin-secreting pituitary adenomas. Surgical intervention, often via transsphenoidal or craniotomy approaches, is required for compressive lesions. Radiation therapy may be considered in selected cases. Multidisciplinary care involving endocrinology, neurosurgery, and ophthalmology is often necessary.
The prognosis varies depending on the etiology, duration of compression, and severity of visual loss at presentation. Early diagnosis and treatment improve the likelihood of visual recovery. However, delayed treatment may result in permanent visual deficits. Complications can include persistent visual loss, hormonal imbalances, and life-threatening conditions such as pituitary apoplexy. Regular follow-up with visual field testing and imaging is essential to monitor disease progression and treatment response.
- Published on
Ophthalmology – Chemical Burns
Chemical burns of the eye are serious ocular injuries caused by exposure to corrosive substances such as acids, alkalis, or irritants including solvents and oxidizing agents. These injuries may affect not only the ocular surface but also surrounding facial tissues and, in severe cases, deeper intraocular structures. Alkali burns are generally more severe than acid burns because they penetrate tissues rapidly and cause extensive cellular damage. Chemical eye injuries account for approximately 7–10% of all ocular trauma and are most commonly occupational, particularly among men due to higher industrial exposure.
The severity of injury depends on both the nature of the chemical and the duration of exposure. Alkalis (e.g., ammonia, sodium hydroxide) cause saponification of cell membranes and deep tissue penetration, leading to widespread destruction. In contrast, acids tend to cause protein coagulation, forming a barrier that limits deeper penetration (with the exception of hydrofluoric acid). Damage mechanisms include protein denaturation, collagen disruption, vascular ischemia, and depletion of essential substances such as ascorbate, which impairs healing.
Patients typically present with acute symptoms such as severe pain, photophobia, tearing, blurred vision, and involuntary eyelid closure (blepharospasm). A detailed history, including the type of chemical exposure, is critical. On examination, findings may include corneal epithelial defects, limbal ischemia (seen as pale or blanched areas), stromal haze or opacity, conjunctival damage, and anterior chamber inflammation. In severe cases, there may be elevated intraocular pressure, iris damage, or even lens and ciliary body involvement. The injury evolves through acute, intermediate, and late stages, with potential complications including corneal melting, ulceration, scarring, and symblepharon formation.
Diagnosis is primarily clinical, supported by pH testing of the ocular surface to determine whether the offending agent is acidic or alkaline. Grading systems such as Dua’s classification assess the extent of limbal and conjunctival involvement and help predict prognosis. It is important to recognize that clinical findings can evolve rapidly, and repeated assessment is essential.
Management is an ophthalmic emergency and begins immediately with copious irrigation of the eye using saline or balanced solutions, ideally before full examination. The goal is to normalize the ocular surface pH to around 7. After irrigation, any retained particulate matter must be removed. Medical therapy includes intensive lubrication, topical antibiotics to prevent infection, and cautious use of topical steroids to control inflammation. Additional treatments may include ascorbate (to promote collagen synthesis), citrate (to inhibit tissue breakdown), cycloplegics for pain relief, and intraocular pressure–lowering medications if needed. Pain control and supportive care are also essential.
In more severe cases, advanced therapies such as autologous serum drops, amniotic membrane transplantation, or limbal stem cell transplantation may be required. Surgical interventions may also address complications like glaucoma, corneal perforation, or eyelid deformities. Long-term follow-up is crucial to monitor healing and prevent complications.
The prognosis depends largely on the depth and extent of injury. Superficial burns have a good outcome, while severe burns involving the entire limbus and conjunctiva carry a poor prognosis with a high risk of vision loss. Complications can include limbal stem cell deficiency, corneal scarring, glaucoma, cataract formation, and even loss of the eye. Early and aggressive management is critical in improving visual outcomes.
- Published on
Click here to start customizing
- Published on
Ophthalmology – Chalazion
A chalazion is a common eyelid condition characterized by a localized, chronic inflammatory nodule of the posterior eyelid caused by obstruction of a meibomian (sebaceous) gland. It is sometimes referred to as an internal hordeolum, although a true hordeolum (stye) is typically an acute infectious process. In contrast, a chalazion is usually sterile and represents a lipogranulomatous inflammatory reaction. An external hordeolum involves the glands of Zeis or Moll at the eyelid margin, whereas a chalazion arises deeper within the tarsal plate.
Chalazia are the most common eyelid lesions encountered in clinical practice. Risk factors include poor eyelid hygiene, acne rosacea, and dry eye syndrome. These conditions contribute to dysfunction of the meibomian glands, leading to blockage of gland openings and retention of sebaceous secretions. Preventive strategies focus on maintaining good lid hygiene and managing associated conditions such as rosacea and dry eye.
The pathophysiology involves obstruction of the meibomian gland orifice, preventing normal secretion of lipid material onto the tear film. This retained material leaks into surrounding tissue, triggering a granulomatous inflammatory response. Although bacteria such as Staphylococcus aureus may play a role in initial blockage or inflammation, the lesion itself is typically noninfectious.
Clinically, patients may initially present with a tender, red swelling of the eyelid in the acute phase. Over time, this evolves into a painless, firm, well-defined nodule within the eyelid. Some patients may notice blurred vision due to induced astigmatism from pressure on the cornea. Examination typically reveals a localized eyelid lump, blocked meibomian gland orifices, and sometimes associated blepharitis or rosacea.
Diagnosis is primarily clinical. Imaging such as CT scan is only indicated if complications like orbital cellulitis are suspected. Importantly, recurrent or atypical lesions should be biopsied to exclude sebaceous (meibomian gland) carcinoma. Histologically, chalazia show a granulomatous reaction with lipid-laden macrophages and multinucleated giant cells.
Management begins conservatively. First-line treatment includes warm compresses applied several times daily to promote drainage, along with topical antibiotics or mild steroid-antibiotic combinations if inflammation is significant. If the lesion persists, second-line options include incision and curettage or intralesional corticosteroid injection (e.g., triamcinolone). Recurrent cases warrant further evaluation and possible biopsy.
The prognosis is excellent, with most lesions resolving either spontaneously or with treatment. However, complications such as eyelid scarring or entropion can occur rarely. A key clinical point is that recurrent chalazia should always raise suspicion for underlying malignancy, particularly meibomian gland carcinoma, and must be investigated appropriately.
A chalazion is a common eyelid condition characterized by a localized, chronic inflammatory nodule of the posterior eyelid caused by obstruction of a meibomian (sebaceous) gland. It is sometimes referred to as an internal hordeolum, although a true hordeolum (stye) is typically an acute infectious process. In contrast, a chalazion is usually sterile and represents a lipogranulomatous inflammatory reaction. An external hordeolum involves the glands of Zeis or Moll at the eyelid margin, whereas a chalazion arises deeper within the tarsal plate.
Chalazia are the most common eyelid lesions encountered in clinical practice. Risk factors include poor eyelid hygiene, acne rosacea, and dry eye syndrome. These conditions contribute to dysfunction of the meibomian glands, leading to blockage of gland openings and retention of sebaceous secretions. Preventive strategies focus on maintaining good lid hygiene and managing associated conditions such as rosacea and dry eye.
The pathophysiology involves obstruction of the meibomian gland orifice, preventing normal secretion of lipid material onto the tear film. This retained material leaks into surrounding tissue, triggering a granulomatous inflammatory response. Although bacteria such as Staphylococcus aureus may play a role in initial blockage or inflammation, the lesion itself is typically noninfectious.
Clinically, patients may initially present with a tender, red swelling of the eyelid in the acute phase. Over time, this evolves into a painless, firm, well-defined nodule within the eyelid. Some patients may notice blurred vision due to induced astigmatism from pressure on the cornea. Examination typically reveals a localized eyelid lump, blocked meibomian gland orifices, and sometimes associated blepharitis or rosacea.
Diagnosis is primarily clinical. Imaging such as CT scan is only indicated if complications like orbital cellulitis are suspected. Importantly, recurrent or atypical lesions should be biopsied to exclude sebaceous (meibomian gland) carcinoma. Histologically, chalazia show a granulomatous reaction with lipid-laden macrophages and multinucleated giant cells.
Management begins conservatively. First-line treatment includes warm compresses applied several times daily to promote drainage, along with topical antibiotics or mild steroid-antibiotic combinations if inflammation is significant. If the lesion persists, second-line options include incision and curettage or intralesional corticosteroid injection (e.g., triamcinolone). Recurrent cases warrant further evaluation and possible biopsy.
The prognosis is excellent, with most lesions resolving either spontaneously or with treatment. However, complications such as eyelid scarring or entropion can occur rarely. A key clinical point is that recurrent chalazia should always raise suspicion for underlying malignancy, particularly meibomian gland carcinoma, and must be investigated appropriately.
